Audentes Therapeutics, Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Audentes Therapeutics, Inc. had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $5.28 million as of 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2017-11-14
- 2017-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $5.28M.
- 2017-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $5.27M.
- 2017-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $5.19M.
- 2016-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $5.09M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2017-09-30 | $5.28M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $5.27M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $5.19M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $5.09M 10-Q · filed 2017-11-14 |
| 2016-09-30 | $5.28M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $5.15M 10-Q · filed 2016-09-01 |
| 2015-12-31 | $4.41M 10-K · filed 2017-03-13 |